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Abstract
Objective:  To establish a relationship between esophageal squamous cell diseases and the
expression of human telomerase reverse transcriptase (hTERT) and Eyes absent 4 (EYA4) mRNA
in peripheral blood mononuclear cells.
Methods: Subjects were 50 patients with esophageal squamous cell carcinoma (ESCC), 50 with
dysplasia (ESCD), 50 with basal cell hyperplasia (BCH) and 50 controls. All subjects were residents
of Feicheng County, Shandong Province, China , diagnosed by histopathology. Expression of hTERT
and EYA4 mRNA in peripheral blood was determined by semiquantitative reverse transcription-
polymerase chain reaction (RT-PCR).
Results: The hTERT and EYA4 mRNA positive expression increased according to disease severity.
At the cut-off value of ≥ 0.2, the positive expression rates of EYA4 were 14% for controls, 20.0%
for BCH, 26% for ESCD and 52% for ESCC, respectively. At the cut-off value of ≥ 0.8, the positive
expression rates of hTERT in the four groups were 24%, 30.0%, 52% and 80%, respectively. Using
a positive value of 0.47 for EYA4, the testing sensitivities in the ESCD and ESCC groups were 4%
and 16%, respectively, and the testing specificity increased to 100%. Using a positive value of 1.0
for hTERT, the testing sensitivities in the ESCD and ESCC groups were 48% and 60%, respectively,
and the testing specificity increased to 72%. The testing sensitivities in the predicting ESCD and
ESCC in the discriminant model including EYA4 and hTERT and the five traditional risk factors (sex,
age, smoking, alcohol drinking, and family history of esophageal cancer) were 70% and 80%, and
testing specificities were 76% and 88% respectively. However, the testing sensitivities and
specificities in the predicting ESCD and ESCC in the model only including the above five traditional
risk factors were lower than that in the former case.
Conclusion: EYA4 and hTERT mRNA expression increased with the severity of esophageal
pathological changes and may be useful for identifying high-risk endoscopy candidates or for
monitoring changes in premalignant esophageal lesions.
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Background
Cancer cells release protein markers into the peripheral
blood, but these are difficult to detect in the serum at the
early stage of cancer. However, in the peripheral blood,
circulating mononuclear cells may phagocytose cancer or
precancer cells and, thereby, express epithelial markers
within their phagocytosed contents. It is possible that
tumor markers will show up in mononuclear cells before
they themselves could be detected in the circulation.
Therefore, mRNA expression of the genotype of these
cells, in theory, can improve the sensitivity of detection of
early cancers.
The human telomerase reverse transcriptase (hTERT gene)
mRNA expression is the most general molecular marker
for the identification of human cancer and can be detected
in 85% of all tumors, whereas most healthy tissues exhibit
little or no expression [1-4]. In healthy esophagus tissue,
hTERT expression is predominantly localized in the basal
cell layers of the columnar epithelium [5]. Differential
hTERT expression between tumor tissues and healthy tis-
sues makes this gene a promising marker for the detection
of tumor cells [6,7].
Eyes absent 4 (EYA4) is one of four members of the EYA
gene family that is homologous to the eyes absent gene in
Drosophila [8-10]. Eyes absent works as a key regulator of
ocular differentiation and may also modulate apoptosis.
Recently, the value of methylated EYA4 as a marker for
Barrette's esophagus and esophageal adenocarcinoma has
been suggested [11,12]. However, to our knowledge, no
reports have yet linked expression of the EYA4 gene link-
age with esophageal squamous cell carcinoma (ESCC).
Endoscopic screening with Lugol dye and pathologic eval-
uation are useful screening tools for early stage esophageal
cancer and for ascertaining the different stages of esopha-
geal carcinogenesis in populated areas with high inci-
dence [13]. However, the lack of strict scientific methods
for determining high-risk persons who should undergo
endoscopic testing, and the resulting cost-efficiency
issues, currently impede this type of screening. Even in
areas with high incidence of ESCC, the detection rate of
ESCC in situ or at early stage is very low. A crucial require-
ment is a reliable method for distinguishing healthy per-
sons and high-risk persons in need of an endoscopic test.
For this reason, in the present study, our aim was to estab-
lish a relationship between the expression of hTERT and
EYA4 mRNA in peripheral blood mononuclear cells,
which may phagocytose cancer or precancer cells and
express epithelial markers within their phagocytosed con-
tents, with the progressive stages of carcinogenesis of the
esophagus. The overall goal is to develop an evaluation
criterion that will allow persons living in high-incidence
cancer areas and at high risk for ESCC to be included in
endoscopic screening programs.
Methods
Subjects
The subjects consisted of 50 patients diagnosed with
ESCC (12 in situ and 38 invasive carcinomas), 50 cases
with esophageal squamous cell dysplasia (ESCD), 50
cases with basal cell hyperplasia (BCH), and 50 controls
in the endoscopic screening program from January 2004
to December 2006 in Feicheng county, China. Any
patients with history of nephrosis, dermatosis, lung and
head-and-neck diseases, liver diseases, diabetes, or cardio-
vascular diseases including coronary heart disease, angina
pectoris, myocardial infarction, cardiac arrhythmia, heart
failure diagnosed via general medical check, electrocardi-
ogram and abdomen supersonic inspection were
excluded.
All subjects took part in the screening program by under-
going an endoscopic staining examination with 1.2%
iodine solution, and biopsies of the subjects were taken
from non-staining areas of mucosa. Two pathologists
took the biopsies of mucosa for separate pathologic eval-
uation. Fifty controls that had non-staining areas of
mucosa and diagnosed as normal mucosa were also
included.
The study protocol was approved by the Shandong Acad-
emy of Medical Sciences Ethics Committee and an
informed consent was obtained from each subject. A
questionnaire form was used to interview all of the sub-
jects and included sociodemographic characteristics, alco-
hol use, tobacco use, and family history of esophageal
cancer. A 4 ml peripheral vein blood sample was drawn
into sterile cryovials containing 0.5 ml anticoagulation
reagent. The blood samples were stored at -70°C until
used for assays. In the ESCC group, 20 specimens of ESCC
tissues were obtained for testing the correlation of hTERT
and EYA4 mRNA expression in peripheral blood mono-
nuclear cells with that in ESCC tissues.
RT-PCR of hTERT and EYA4 from peripheral blood
Total RNA was extracted from peripheral blood mononu-
clear cells by the acid guanidium-isothiocyanate-phenol-
chloroform method.
The primers for hTERT were 5'-ACC GTC TGC GTG AGG
AGA TC-3' and 5'-CCG GTA GAA AAA GAG CCT GTT C-
3'.
The primers for EYA4 were 5'-TCC CCA CAG CTG TAT
CCT TC-3'and 5'-AAC TGA GGC AGC CAC TCT GT-3'
[12]. The quality of RNA and cDNA synthesis was ascer-Journal of Experimental & Clinical Cancer Research 2009, 28:145 http://www.jeccr.com/content/28/1/145
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tained by amplification of human β-actin as an internal
control.
The primers for β-actin were 5'-GTGGGGCGCCCCAG-
GCACCA-3' and 5'-CTCCTTAATGTCACGCACGATTTC-3'
[14].
The primers amplified 131 bp, 250 bp, and 540 bp prod-
ucts from hTERT, EYA4, and β-actin, respectively.
RNA was reverse transcribed into cDNA using a First
Strand cDNA Synthesis Kit (Promega, Madison, USA).
After reverse transcription, 3 μl of synthesized cDNA was
amplified in a 50 μl PCR reaction mix containing 20 mM
(NH4)2SO4, 75 mM Tris-HCl (pH8.8), 0.01%Tween20, 2
mM MgCl2, 0.2 mM dNTP, 0.2 μM of each of the primers
and 1 unit Taq DNA polymerase (Fermentas, Vilnius,
Lithuania). The reaction was performed at 95°C for 5
min, followed by 35 cycles at 94°C for 1 min, 58°C for 1
min and 72°C for 1 min, and a final extension at 72°C for
7 min.
A negative control without template cDNA was performed
with every PCR reaction. After PCR reactions, 10 μl of the
PCR products were electrophoresed on a 1.2 percent agar-
ose gel and visualized by ethidium bromide staining. The
specificity of the PCR products was confirmed by direct
sequencing. Band intensity of ethidium bromide fluores-
cence was measured using NIH Image Analysis Software
Ver 1.61 (National Institute of Health, Bethesda, MD,
USA). Bands intensities were determined by comparison
to those of β-actin.
hTERT and EYA4 RT-PCR in ESCC tissues
RT-PCR was also used to evaluate hTERT and EYA4 mRNA
expression in 20 specimens of ESCC tissues sampled from
the cancer group for confirmation of the accuracy of
hTERT and EYA4 mRNA expression in peripheral blood.
The RNA in the tissue was extracted by the same method
as that described for the peripheral blood cells.
Statistical Analysis
Pearson's χ2 test was used to examine differences in socio-
demographic characteristics, alcohol use, tobacco use,
and family history of esophageal cancer among the cancer
and control groups. Smoking index equals the number of
cigarettes per day multiplied by smoking years. Alcohol
drinking index equals the amount of alcohol drinking per
month multiplied by drinking years. The association
between the expression of hTERT and EYA4 mRNA and
esophageal cancers was evaluated by odds ratios (ORs)
and 95% confidence intervals (95% CIs), which were cal-
culated using a multinomial logistic regression model
after adjusting for the variables of age, smoking index and
drinking index.
The sensitivity and specificity was calculated using the
receiver operating characteristic (ROC) curves and the
area under curve (AUC) for hTERT and EYA4 mRNA
expression. The ratios of the band intensity of hTERT or
EYA4 to β-actin are used the cut off values. The cut-off
points of that were used in the discriminating between
positive and negative status with the two biomarkers.
In order to determine high-risk people who need to take
the endoscopic examination in the screening survey of
esophageal lesions, the determinant regression model was
used. In these models, hTERT and EYA4 combined with
the risk factors including sex, age, smoking, alcohol drink-
ing and family history of esophageal cancer, which were
found by a traditional epidemiological case-control study
in this area, are independent variables. The results of these
model output will display the ability to distinguish cases
and the normal controls. All statistical analyses were per-
formed using SPSS version 15.0 software package (SPSS,
Chicago, III).
Results
hTERT and EYA4 mRNA expression
Sociodemographic characters and possible risk variables
in the cancer and control groups are summarized in Table
1. The univariate analysis showed significant differences
in the percentages of age and alcohol drinking index
between the cancer and control groups.
The Spearman's correlation coefficient between hTERT
and EYA4 was 0.385 (P < 0.05). The correlation coeffi-
cients between hTERT or EYA4 and the four groups were
0.484 and 0.213, respectively (P < 0.05).
The hTERT and EYA4 mRNA expression in the assay is
shown in Table 2, Figure 1 and Figure 2. There was signif-
icant increase for the positive rates of hTERT or EYA4
mRNA expression in peripheral blood mononuclear cells
with the progressive stages from normal cells to cancer in
the esophageal carcinogenesis.
As shown in Table 2, the band intensity ratios of EYA4
mRNA with a β-actin positive cut-off value of  0.2 indi-
cated that EYA4 mRNA expression increased progressively
according to the severity of the pathology: controls 14.0%
(7/50), BCH 20.0% (10/50), ESCD 26.0% (13/50), and
ESCC 52.0% (26/50). There was a significant linear-by-
linear association of the four groups.
The band intensity ratios of hTERT mRNA with a β-actin
positive cut-off value of  0.8 indicated that hTERT
mRNA expression also increased with the progressively
severity of the disease, and the positive expression rates in
the four groups were 24% (12/50), 30.0% (15/50), 52%
(26/50) and 80% (40/50), respectively.Journal of Experimental & Clinical Cancer Research 2009, 28:145 http://www.jeccr.com/content/28/1/145
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The Spearman correlation coefficient of hTERT and EYA4
mRNA expression in peripheral blood mononuclear cells
and in the tissues was 0.80 (P < 0.01). This indicated that
the expression of the two markers in peripheral blood
mononuclear cells was accurate.
As shown in Table 3, multinomial logistic regression anal-
ysis gave odds ratios (ORs) for EYA4 and hTERT mRNA
expression also increased with the severity of the diseases
after adjustment for age, gender, smoking index, drinking
index and family history of esophageal cancer. However,
only the OR value of the EYA4 mRNA expression in ESCC
group was significant.
The feasibility of prediction of high-risk persons
As shown in Table 4, using ratios of EYA4 mRNA expres-
sion to β-actin with a positive cut-off value of 0.47, testing
sensitivities in ESCD and ESCC became 4% and 16%,
respectively, and the testing specificity increased to 100%,
where no false positive samples were existed in the study.
Using ratios of hTERT mRNA expression to β-actin with a
positive cut-off value of ≥ 1.5, the testing sensitivities and
specificities in ESCD and ESCC were 12% and 90%, 12%
and 94%, respectively.
Table 5 showed the feasibility of prediction of high-risk
persons. It is clear displayed when the hTERT and EYA4
mRNA expression and the traditional risk factors (sex, age,
smoking, drinking, and family history of ESCC) included
in the discriminat model 1 and model 3, the sensitivity
and specificity was 80% and 88% for predicted ESCC, and
70% and 76% for predicted ESCD, respectively. These
results were higher than the results of predicted ESCC and
ESCD in the discriminat model 2 and model 4, including
the above five traditional risk factors only. The results
indicated that hTERT and EYA4 mRNA expression com-
bined with the traditional risk factors are useful to set up
a discriminating function model, which maybe used to
determine a high-risk person needing to take the endo-
scopic testing in the high-incidence area. However, in
these models, nearly half or more than half of all cases in
each group were ungrouped in the analysis.
Discussion
In a retrospective death survey carried out in the 1970s,
Feicheng County was second only to Lin County of Henan
Province as the area with the highest incidence of ESCC
[15]. For the past 35 years, the mortality rate of ESCC has
remained high in Feicheng County [16]. Epidemiological
Table 1: Demographic characteristics and possible risk variables of the study subjects*
Variables Control s
(n = 50)
BCH
(n = 50)
ESCD
(n = 50) 
ESCC
(n = 50)
Gender, n(%)
male 35(70.0) 35(70.0) 30(60.0) 30(60.0)
female 15(30.0) 15(30.0) 20(40.0) 20(40.0)
age(years), n(%)
40~50 19(38.0) 19(38.0) 8(16.0) 7(14.0)
51~60 18(36.0) 18(36.0) 25(50.0) 23(46.0)
61~70 13(26.0) 13(26.0) 17(34.0) 20(40.0)
Smoking index, n(%)
Never 24(48.0) 24(48.0) 25(50.0) 24(48.0)
1~600 13(26.0) 13(26.0) 14(28.0) 14(28.0)
≥ 600 13(26.0) 13(26.0) 11(22.0) 12(24.0)
Drinking index, n(%)
Never 19(38.0) 19(38.0) 26(52.0) 25(50.0)
< 100 15(30.0) 15(30.0) 14(28.0) 8(16.0)
≥ 100 16(32.0) 16(32.0) 10(20.0) 17(34.0)
Family history of esophageal cancer, n(%)
No 39(78.0) 39(78.0) 43(86.0) 44(88.0)
yes 11(22.0) 11(22.0) 7(14.0) 6(12.0)
Education:
Illiterate or primary school 9(18.0) 8(16.0) 25(50.0) 37(74.0)
Junior high school and over 41(82.0) 42(84.0) 25(50.0) 13(26.0)
per capita annual income($)
< 300 6(12.0) 2(4.0) 12(24.0) 19(38.0)
300- 16(32.0) 15(30.0) 8(16.0) 22(44.0)
≥ 600 28(56.0) 33(66.0) 30(60.0) 9(18.0)
*:There are significant differences of age, alcohol drinking index, education and per capita annual income among the four groups, and the values of 
Chi-square test are 29.044(P < 0.001), 13.974(P = 0.03), 48.436(P < 0.001) and 38.973(P < 0.001), respectively. Smoking index = cigarette/day × 
number of smoking years. Alcohol drinking index = ((white spirits(g) × 0.38+ wine (g) × 0.12+ beer(g) × 0.04)/month ×12)/365 day. BCH, Basal cell 
hyperplasia; ESCD, esophageal squamous cells dyspalsia; ESCC, esophageal squamous cells cancer.Journal of Experimental & Clinical Cancer Research 2009, 28:145 http://www.jeccr.com/content/28/1/145
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research has shown that there is a difference in the risk fac-
tors related to ESSC in the two areas [17,18].
We carried out a program of endoscope screening for
esophageal lesions using 1.2% iodine staining between
January 2004 and December 2006 in Fetching County.
The study included all of the residents aged from 40 to 69,
who agreed to participate in the program after explana-
tion of the purpose of the study. Prior to this study, we
had conducted a case-control study of esophageal cancer
based on hospital data from Feicheng. This study found
that esophageal cancer was associated with the risk factors
of smoking, alcohol drinking and family history of the
disease. In the screening explanation, we therefore espe-
cially encouraged those persons who were heavy smokers
or drinkers, or who had a positive family history of
esophageal cancer, to participate in the study and undergo
endoscopic inspection [19].
Based on the screening data, we carried out another case-
control study. There were 235 ESCC cases (70 early can-
cers identified in screening program, 183 were advanced
cancer diagnosed in hospitalized patients) and 8159 con-
trols who were confirmed clear by endoscopy and
mucosal staining in the screening program. After adjust-
ing for the three confounders (age, sex and education), we
found that smoking and alcohol drinking were the top
ranked risk factors for esophageal cancer. When smoking
and alcohol drinking were combined, the OR was 2.73
Expression of hTERT mRNA in peripheral blood mononu- clear cells among cases of esophageal squamous cell lesions  and controls Figure 1
Expression of hTERT mRNA in peripheral blood 
mononuclear cells among cases of esophageal squa-
mous cell lesions and controls. M: DNA ladders; lane 1: 
cases with basal cells hyperplasia; lane 2: normal controls; 
lane 3: cases with esophageal squamous cell carcinoma; lane 
4: cases with esophageal squamous cell dysplasia; lane 5: neg-
ative control (no cDNA). The PCR products are 131 bp for 
hTERT(A) and 540 bp for β-actin (B).
Expression of EYA4 mRNA in peripheral blood mononuclear  cells among cases of esophageal squamous cell lesions and  controls Figure 2
Expression of EYA4 mRNA in peripheral blood 
mononuclear cells among cases of esophageal squa-
mous cell lesions and controls. M: DNA ladders; lane 1: 
normal controls; lane 2: cases with basal cells hyperplasia; 
lane 3: cases with esophageal squamous cell carcinoma; lane 
4: cases with esophageal squamous cell dysplasia; lane 5: neg-
ative control (no cDNA). The PCR products are 250 bp for 
EYA4 (A) and 540 bp for β-actin (B).
Table 2: Rates of detection of EYA4 and hTERT mRNA in 
peripheral blood mononuclear cells of the study subjects
Control subjects
(n = 50)
BCH
(n = 50)
ESCD
(n = 50) 
ESCC
(n = 50)
EYA4
≥ 0.2, n(%) 7(14.0) 10(20.0) 13(26.0) 26(52.0)
< 0.2, n(%) 43(86.0) 40(80.0) 37(74.0) 24(48.0)
hTERT
≥ 0.8, n(%) 12(24.0) 15(30.0) 26(52.0) 40(80.0)
< 0.8, n(%) 38(76.0) 35(70.0) 24(48.0) 10(20.0)
×:χ2 = 19.643, P < 0.001, and linear-by-linear association = 16.246, P < 
0.001 for EYA4 mRNA expression in the four groups; χ2 = 69.149, P < 
0.001 and linear-by-linear association = 41.994, P < 0.001 for hTERT 
mRNA expression in the four groups. BCH, Basal cell hyperplasia; 
ESCD, esophageal squamous cells dyspalsia; ESCC, esophageal 
squamous cells cancer.Journal of Experimental & Clinical Cancer Research 2009, 28:145 http://www.jeccr.com/content/28/1/145
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(95%CI: 1.54-4.82), and the proportional attribute rela-
tive risk was 51.47 per cent for males. When smoking,
alcohol drinking and family history of esophageal cancer
were combined, the OR was 3.40 (95%CI: 1.68-6.89), and
the proportional attribute relative risk was 15.4 per cent
for males [20]. The risk factors identified in the study were
consistent with the results of our previous case-control
study based on hospital data.
Although there was no test fee charged for our screening
survey, the response rate of residents participating was
very low. The main reason was lack of a method to iden-
tify high-risk persons who may be suffering from esopha-
geal premalignant diseases, and to persuade these persons
to participate in the endoscopic examination.
Telomeres are nucleoprotein complexes that constitute
the ends of eukaryotic chromosomes [21]. To maintain
telomere length of telomerase is necessarily to indefinite
proliferation of human cells. The human telomerase com-
plex consists of human telomerase-associated RNA (hTR),
providing the template for telomeric repeat synthesis, and
human telomerase reverse transcriptase (hTERT), repre-
senting the catalytic subunit of the complex [22]. One
Chinese study reported that hTERT mRNA positive expres-
sion was 96.6% (28/29) of ESCC, 48.9% (23/47) of dys-
plasia, and 7.5% (2/29) of normal tissues [23].
In our study, the positive rates of hTERT mRNA expression
in peripheral blood mononuclear cells increased with the
progressive stages of the esophageal carcinogenesis. How-
ever, it is clear that the positive expression rate of hTERT
in peripheral blood mononuclear cells of the normal con-
trols in our study is higher than that in the normal tissues
of the above paper reported. Accordingly, Lord reported
on higher hTERT levels in histological normal squamous
esophagus tissues from cancer patients compared with
hTERT levels found in normal esophageal tissues from
patients with no cancer [24].
Most interestingly, results of the studies of esophagus ade-
nocarcinoma also showed that hTERT not only expressed
in all cancer tissues but also in all adjacent non-cancerous
tissues. Moreover, the trend toward longer telomeres with
increasing depth of tumor invasion not only suggested for
telomere lengths in cancer tissue but also for telomere
Lengths in adjacent non-cancerous Barrett mucosa [25].
It is the first time report the positive rate of hTERT in
peripheral blood mononuclear cells of the normal con-
trols in our study. The mechanism is not clear.
Table 3: Association of the expression of EYA4 and hTERT 
mRNA in peripheral blood mononuclear cells with esophageal 
diseases
BCH
(n = 50)
ESCD
(n = 50) 
ESCC
(n = 50)
EYA4 mRNA
OR(95%CI) 1.32(0.47-3.66) 1.85(0.69-4.94) 5.69(2.23-14.53)
OR(95%CI)+ 1.90(0.62-5.81) 1.72(0.54-5.45) 5.07(1.56-16.52)
hTERT mRNA
OR(95%CI) 0.90(0.33-2.45) 1.18(0.42-3.36) 2.03(0.63-6.55)
OR(95%CI)+ 1.10(0.37-3.26) 1.12(0.34-3.72) 2.87(0.63-13.07)
+: OR(95%CI) was adjusted for age, smoking, drinking, income and 
family history of esophageal carcinoma. BCH, Basal cell hyperplasia; 
ESCD, esophageal squamous cells dyspalsia; ESCC, esophageal 
squamous cells cancer.
Table 4: The sensitivity and specificity of EYA4 and hTERT mRNA expression
ESCC ESCD BCH
item Cut off 
level
Sensitivity
(%)
Specificity
(%)
Sensitivity
(%)
Specificity
(%)
Sensitivity
(%)
Specificity
(%)
hTERT
≥ 0.3 96.0 5.0 98.0 5.0 98.0 5.0
0.5- 88.0 19.0 93.0.0 22.0 90.0 22.0
1.0- 60.0 72.0 48.0 72.0 31.0 72.0
1.5- 12.0 94.4 12.0 90.0 5.0 90.0
AUC 0.820 0.671 0.566
EYA4
≥ 0.20 76.0 64.0 36.0 64.0 12.0 64
0.30- 40.0 73.0 27.0 73.0 0.0 73
0.40- 20.0 90.0 10.0 90.0 0.0 90
0.47- 16.0 100.0 4.0 100.0 0.0 100.0
AUC 0.693 0.553 0.520
NOTE. AUC:area under curve. The cut-off levels (the band intensity ratios of hTER or EYA4 to β-actin) written in bold are the cut-off points that 
used in the discriminating between positive and negative status with different markers. BCH, Basal cell hyperplasia; ESCD, esophageal squamous 
cells dyspalsia; ESCC, esophageal squamous cells cancer.Journal of Experimental & Clinical Cancer Research 2009, 28:145 http://www.jeccr.com/content/28/1/145
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The main discovery in the present study was EYA4 mRNA
expression in peripheral blood mononuclear cells
increased with the stages of progressive carcinogenesis of
esophagus. Although the positive expression rates were
relative low, using a positive cut-off value of 0.47, testing
sensitivities were 4% and 16% for ESCD and ESCC,
respectively, but the testing specificity increased to 100%,
where no false positive cases were existed in the study.
Because there was a low degree of correlation between
hTERT and EYA4 mRNA expression in the present study,
both of them were dependent biomarkers. The discrimi-
nating ability between positive and negative status with
either hTERT or EYA4 is too low to predict the high-risk
persons.
In the study, we try to use the discriminating regression
model to increase the power of predicting high-risk per-
sons. Comparing with that in the discriminate models
including independent variables of sex, age, smoking,
drinking, family history of ESCC, in the model including
the variables of hTERT, EYA4 and the five variables in the
models increased the sensitivities and specificities of pre-
dicting ESCD and ESCC increased.
This knowledge may be useful in identifying high-risk per-
sons who need to take part in the endoscopic test. It could
be an effective method for monitoring the progress of pre-
malignant esophageal lesions among subjects, who live in
areas with high-incidence of cancer. A prospective study in
the future needs to confirm these possibilities.
Conclusion
In this study, we found out that the intensity of EYA4 and
hTERT mRNA expression increases with the severity of
esophageal pathological changes, which can bring forth
values for monitoring the progress of premalignant
esophageal lesions.
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Table 5: The sensitivity and specificity for the positive expression of hTERT and EYA4 mRNA combing the traditional risk factors by 
discrimination analysis
Model Original group Predicted group membership sensitivity Specificity
1 Discrimination of ESCC/control: control ESCC
control 44 6 80.0% 88.0%
ESSC 10 40
Ungrouped cases 54 46
2 Discrimination of ESCD/control: control ESCC
control 38 12 64.0% 76.0%
ESCC 18 32
Ungrouped cases 44 56
3 Discrimination of ESCD/control: control ESCD
control 38 12 70.0% 76.0%
ESCD 15 35
Ungrouped cases 27 73
4 Discrimination of ESCD/control: control ESCD
control 39 11 64.0% 76.0%
ESCD 18 32
Ungrouped cases 41 59
Note: The discrimination model 1 and model 3 included variables of the hTERT and EYA4 and the five traditional risk factors (sex, age, smoking, 
alcohol drinking and family history of esophageal cancer). The discrimination model 2 and model 4 only included the five traditional risk factors. 
ESCD, esophageal squamous cells dyspalsia; ESCC, esophageal squamous cells cancer.Publish with BioMed Central    and   every 
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